Cell Cryopreservation Equipment Market Size, Share & Trends Analysis Report By Product (Equipment, Consumables/Accessories), By Application (Stem Cells, Reproductive Cells, Bioproduction Cell Lines), By End Use, By Region, And Segment Forecasts, 2025 - 20
Description
Cell Cryopreservation Equipment Market Summary
The global cell cryopreservation equipment market size was estimated at USD 2.20 billion in 2024 and is projected to reach USD 5.65 billion by 2033, growing at a CAGR of 11.08% from 2025 to 2033. The growing use of regenerative medicine, the expansion of stem cell banking and biobanking operations, and the rise in cell-based research drive the market growth.
Growing Use of Diverse Cryoprotective Agents
The need for accurate and dependable cryopreservation procedures is highlighted by the growing use of different cryoprotective agents, such as DMSO, Cell Banker series, trehalose, glycerol, and propylene glycol, across a variety of biological specimens, including stem cells, embryos, oocytes, hepatocytes, red blood cells, spermatozoa, and dental/soft tissues. The need for sophisticated cryopreservation equipment with precise temperature control, automation, and compatibility with various preservation media continues to grow as labs and biobanks handle increasingly sensitive and diverse samples that require freezing and vitrification conditions.
The need for long-term, high-viability storage of patient-specific biological samples is also being increased by the growing trend toward personalized and cell-based therapies, which is encouraging investment in cryopreservation infrastructure. To ensure consistent cell survival and adherence to evolving standards, end users are increasingly implementing next-generation cryopreservation equipment with enhanced monitoring, automation, and data-logging capabilities, as regulatory bodies emphasize the importance of quality assurance, sample traceability, and standardized preservation protocols.
Rising use of cell-based therapies & regenerative medicine
The accelerating adoption of stem cell therapy, cell-based treatments, and regenerative medicine is a major driver of demand for cell cryopreservation equipment. Since therapeutic cells must remain viable and genetically stable throughout extraction, transport, processing, and clinical administration, cryopreservation is essential for long-term storage without compromising cell integrity. As the pipeline of cellular therapeutics expands, cryopreservation has become a critical step in therapy development, quality control, and delivery.
Growing numbers of clinical trials and commercial-stage cell therapies are prompting research institutions, biobanks, CDMOs, and pharmaceutical companies to scale their cryopreservation capacity. Controlled-rate freezers, ultra-low-temperature systems, smart inventory solutions, and liquid nitrogen-based platforms are therefore central to industrial bioprocessing and global distribution of advanced cell therapies.
Global Cell Cryopreservation Equipment Market Report Segmentation
This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global cell cryopreservation equipment market report based on product, application, end use, and region:
The global cell cryopreservation equipment market size was estimated at USD 2.20 billion in 2024 and is projected to reach USD 5.65 billion by 2033, growing at a CAGR of 11.08% from 2025 to 2033. The growing use of regenerative medicine, the expansion of stem cell banking and biobanking operations, and the rise in cell-based research drive the market growth.
Growing Use of Diverse Cryoprotective Agents
The need for accurate and dependable cryopreservation procedures is highlighted by the growing use of different cryoprotective agents, such as DMSO, Cell Banker series, trehalose, glycerol, and propylene glycol, across a variety of biological specimens, including stem cells, embryos, oocytes, hepatocytes, red blood cells, spermatozoa, and dental/soft tissues. The need for sophisticated cryopreservation equipment with precise temperature control, automation, and compatibility with various preservation media continues to grow as labs and biobanks handle increasingly sensitive and diverse samples that require freezing and vitrification conditions.
The need for long-term, high-viability storage of patient-specific biological samples is also being increased by the growing trend toward personalized and cell-based therapies, which is encouraging investment in cryopreservation infrastructure. To ensure consistent cell survival and adherence to evolving standards, end users are increasingly implementing next-generation cryopreservation equipment with enhanced monitoring, automation, and data-logging capabilities, as regulatory bodies emphasize the importance of quality assurance, sample traceability, and standardized preservation protocols.
Rising use of cell-based therapies & regenerative medicine
The accelerating adoption of stem cell therapy, cell-based treatments, and regenerative medicine is a major driver of demand for cell cryopreservation equipment. Since therapeutic cells must remain viable and genetically stable throughout extraction, transport, processing, and clinical administration, cryopreservation is essential for long-term storage without compromising cell integrity. As the pipeline of cellular therapeutics expands, cryopreservation has become a critical step in therapy development, quality control, and delivery.
Growing numbers of clinical trials and commercial-stage cell therapies are prompting research institutions, biobanks, CDMOs, and pharmaceutical companies to scale their cryopreservation capacity. Controlled-rate freezers, ultra-low-temperature systems, smart inventory solutions, and liquid nitrogen-based platforms are therefore central to industrial bioprocessing and global distribution of advanced cell therapies.
Global Cell Cryopreservation Equipment Market Report Segmentation
This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global cell cryopreservation equipment market report based on product, application, end use, and region:
- Product Outlook (Revenue, USD Million, 2021 - 2033)
- Equipment
- Freezers
- Liquid Nitrogen Supply Tanks
- Incubators
- Consumables/Accessories
- Cryogenic vials
- Cryogenic tubes
- Cooler boxes/containers
- Others
- Application Outlook (Revenue, USD Million, 2021 - 2033)
- Stem Cells
- Reproductive Cells
- Bioproduction Cell Lines
- Primary Cells
- Others
- End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Biopharmaceutical & Pharmaceutical Companies
- Academic and Research Institutes
- Biobanks
- IVF clinics
- Others
- Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- Thailand
- South Korea
- Latin America
- Brazil
- Argentina
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
150 Pages
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Market Definitions
- 1.2.1. Product
- 1.2.2. Application
- 1.2.3. End Use
- 1.3. Information analysis
- 1.4. Market formulation & data visualization
- 1.5. Data validation & publishing
- 1.6. Information Procurement
- 1.6.1. Primary Research
- 1.7. Information or Data Analysis
- 1.8. Market Formulation & Validation
- 1.9. Market Model
- 1.10. Objectives
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
- Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Growing use of diverse cryoprotective agents
- 3.2.1.2. Rising use of cell-based therapies & regenerative medicine
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. High cost of instruments
- 3.3. Industry Analysis Tools
- 3.3.1. Porter's Five Forces Analysis
- 3.3.2. PESTEL Analysis
- Chapter 4. Cell Cryopreservation Equipment Market: Product Business Analysis
- 4.1. Product Segment Dashboard
- 4.2. Global Cell Cryopreservation Equipment Market Product Movement Analysis
- 4.3. Global Cell Cryopreservation Equipment Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
- 4.4. Equipment
- 4.4.1. Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4.2. Freezers
- 4.4.2.1. Freezers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4.3. Liquid Nitrogen Supply Tanks
- 4.4.3.1. Liquid Nitrogen Supply Tanks Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4.4. Incubators
- 4.4.4.1. Incubators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5. Consumables/Accessories
- 4.5.1. Consumables/Accessories Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5.2. Cryogenic vials
- 4.5.2.1. Cryogenic vials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5.3. Cryogenic tubes
- 4.5.3.1. Cryogenic tubes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5.4. Cooler boxes/containers
- 4.5.4.1. Cooler boxes/containers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5.5. Others
- 4.5.5.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- Chapter 5. Cell Cryopreservation Equipment Market: Application Business Analysis
- 5.1. Application Segment Dashboard
- 5.2. Global Cell Cryopreservation Equipment Market Application, Movement Analysis
- 5.3. Global Cell Cryopreservation Equipment Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
- 5.4. Stem Cells
- 5.4.1. Stem Cells Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.5. Reproductive Cells
- 5.5.1. Reproductive Cells Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.6. Bioproduction Cell Lines
- 5.6.1. Bioproduction Cell Lines Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.7. Primary Cells
- 5.7.1. Primary Cells Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.8. Others
- 5.8.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- Chapter 6. Cell Cryopreservation Equipment Market: End Use Business Analysis
- 6.1. End Use Segment Dashboard
- 6.2. Global Cell Cryopreservation Equipment Market End Use Movement Analysis
- 6.3. Global Cell Cryopreservation Equipment Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
- 6.4. Biopharmaceutical & Pharmaceutical Companies
- 6.4.1. Biopharmaceutical & Pharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5. Academic and Research Institutes
- 6.5.1. Academic and Research Institutes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.6. Biobanks
- 6.6.1. Biobanks Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.7. IVF clinics
- 6.7.1. IVF clinics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.8. Others
- 6.8.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- Chapter 7. Cell Cryopreservation Equipment Market: Regional Estimates & Trend Analysis by Product, Technology, Workflow, Sample Type, & End Use
- 7.1. Regional Dashboard
- 7.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
- 7.3. North America
- 7.3.1. North America Cell Cryopreservation Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.2. U.S.
- 7.3.2.1. Key Country Dynamics
- 7.3.2.2. Competitive Scenario
- 7.3.2.3. Regulatory Framework
- 7.3.2.4. U.S. Cell Cryopreservation Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.3. Canada
- 7.3.3.1. Key Country Dynamics
- 7.3.3.2. Competitive Scenario
- 7.3.3.3. Regulatory Framework
- 7.3.3.4. Canada Cell Cryopreservation Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.4. Mexico
- 7.3.4.1. Key Country Dynamics
- 7.3.4.2. Competitive Scenario
- 7.3.4.3. Regulatory Framework
- 7.3.4.4. Mexico Cell Cryopreservation Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4. Europe
- 7.4.1. Europe Cell Cryopreservation Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.2. UK
- 7.4.2.1. Key Country Dynamics
- 7.4.2.2. Competitive Scenario
- 7.4.2.3. Regulatory Framework
- 7.4.2.4. UK Cell Cryopreservation Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.3. Germany
- 7.4.3.1. Key Country Dynamics
- 7.4.3.2. Competitive Scenario
- 7.4.3.3. Regulatory Framework
- 7.4.3.4. Germany Cell Cryopreservation Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.4. France
- 7.4.4.1. Key Country Dynamics
- 7.4.4.2. Competitive Scenario
- 7.4.4.3. Regulatory Framework
- 7.4.4.4. France Cell Cryopreservation Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.5. Italy
- 7.4.5.1. Key Country Dynamics
- 7.4.5.2. Competitive Scenario
- 7.4.5.3. Regulatory Framework
- 7.4.5.4. Italy Cell Cryopreservation Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.6. Spain
- 7.4.6.1. Key Country Dynamics
- 7.4.6.2. Competitive Scenario
- 7.4.6.3. Regulatory Framework
- 7.4.6.4. Spain Cell Cryopreservation Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.7. Denmark
- 7.4.7.1. Key Country Dynamics
- 7.4.7.2. Competitive Scenario
- 7.4.7.3. Regulatory Framework
- 7.4.7.4. Denmark Cell Cryopreservation Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.8. Sweden
- 7.4.8.1. Key Country Dynamics
- 7.4.8.2. Competitive Scenario
- 7.4.8.3. Regulatory Framework
- 7.4.8.4. Sweden Cell Cryopreservation Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.9. Norway
- 7.4.9.1. Key Country Dynamics
- 7.4.9.2. Competitive Scenario
- 7.4.9.3. Regulatory Framework
- 7.4.9.4. Norway Cell Cryopreservation Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5. Asia Pacific
- 7.5.1. Asia Pacific Cell Cryopreservation Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.2. Japan
- 7.5.2.1. Key Country Dynamics
- 7.5.2.2. Competitive Scenario
- 7.5.2.3. Regulatory Framework
- 7.5.2.4. Japan Cell Cryopreservation Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.3. China
- 7.5.3.1. Key Country Dynamics
- 7.5.3.2. Competitive Scenario
- 7.5.3.3. Regulatory Framework
- 7.5.3.4. China Cell Cryopreservation Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.4. India
- 7.5.4.1. Key Country Dynamics
- 7.5.4.2. Competitive Scenario
- 7.5.4.3. Regulatory Framework
- 7.5.4.4. India Cell Cryopreservation Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.5. Australia
- 7.5.5.1. Key Country Dynamics
- 7.5.5.2. Competitive Scenario
- 7.5.5.3. Regulatory Framework
- 7.5.5.4. Australia Cell Cryopreservation Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.6. Thailand
- 7.5.6.1. Key Country Dynamics
- 7.5.6.2. Competitive Scenario
- 7.5.6.3. Regulatory Framework
- 7.5.6.4. Thailand Cell Cryopreservation Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.7. South Korea
- 7.5.7.1. Key Country Dynamics
- 7.5.7.2. Competitive Scenario
- 7.5.7.3. Regulatory Framework
- 7.5.7.4. South Korea Cell Cryopreservation Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6. Latin America
- 7.6.1. Latin America Cell Cryopreservation Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.2. Brazil
- 7.6.2.1. Key Country Dynamics
- 7.6.2.2. Competitive Scenario
- 7.6.2.3. Regulatory Framework
- 7.6.2.4. Brazil Cell Cryopreservation Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.3. Argentina
- 7.6.3.1. Key Country Dynamics
- 7.6.3.2. Competitive Scenario
- 7.6.3.3. Regulatory Framework
- 7.6.3.4. Argentina Cell Cryopreservation Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7. MEA
- 7.7.1. MEA Cell Cryopreservation Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7.2. South Africa
- 7.7.2.1. Key Country Dynamics
- 7.7.2.2. Competitive Scenario
- 7.7.2.3. Regulatory Framework
- 7.7.2.4. South Africa Cell Cryopreservation Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7.3. Saudi Arabia
- 7.7.3.1. Key Country Dynamics
- 7.7.3.2. Competitive Scenario
- 7.7.3.3. Regulatory Framework
- 7.7.3.4. Saudi Arabia Cell Cryopreservation Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7.4. UAE
- 7.7.4.1. Key Country Dynamics
- 7.7.4.2. Competitive Scenario
- 7.7.4.3. Regulatory Framework
- 7.7.4.4. UAE Cell Cryopreservation Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7.5. Kuwait
- 7.7.5.1. Key Country Dynamics
- 7.7.5.2. Competitive Scenario
- 7.7.5.3. Regulatory Framework
- 7.7.5.4. Kuwait Cell Cryopreservation Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- Chapter 8. Competitive Landscape
- 8.1. Participant Categorization
- 8.2. Strategy Mapping
- 8.3. Company Market Position Analysis, 2024
- 8.4. Participant’s Overview
- 8.4.1. Thermo Fisher Scientific Inc.
- 8.4.1.1. Overview
- 8.4.1.2. Financial Performance
- 8.4.1.3. Product Benchmarking
- 8.4.1.4. Strategic Initiatives
- 8.4.2. Azenta US Inc.
- 8.4.2.1. Overview
- 8.4.2.2. Financial Performance
- 8.4.2.3. Product Benchmarking
- 8.4.2.4. Strategic Initiatives
- 8.4.3. MVE Biological Solutions.
- 8.4.3.1. Overview
- 8.4.3.2. Financial Performance
- 8.4.3.3. Product Benchmarking
- 8.4.3.4. Strategic Initiatives
- 8.4.4. INOXCVA
- 8.4.4.1. Overview
- 8.4.4.2. Financial Performance
- 8.4.4.3. Product Benchmarking
- 8.4.4.4. Strategic Initiatives
- 8.4.5. Haier Biomedical
- 8.4.5.1. Overview
- 8.4.5.2. Financial Performance
- 8.4.5.3. Product Benchmarking
- 8.4.5.4. Strategic Initiatives
- 8.4.6. Kirsch GmbH
- 8.4.6.1. Overview
- 8.4.6.2. Financial Performance
- 8.4.6.3. Product Benchmarking
- 8.4.6.4. Strategic Initiatives
- 8.4.7. Planer, a Hamilton Thorne company
- 8.4.7.1. Overview
- 8.4.7.2. Financial Performance
- 8.4.7.3. Product Benchmarking
- 8.4.7.4. Strategic Initiatives
- 8.4.8. Eppendorf SE
- 8.4.8.1. Overview
- 8.4.8.2. Financial Performance
- 8.4.8.3. Product Benchmarking
- 8.4.8.4. Strategic Initiatives
- 8.4.9. Labtron Equipment Ltd.
- 8.4.9.1. Overview
- 8.4.9.2. Financial Performance
- 8.4.9.3. Product Benchmarking
- 8.4.9.4. Strategic Initiatives
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
